Phaarmasia Current Share Price | Phaarmasia Stock Screener
PHRMASI
Pharmaceuticals
Phaarmasia Current Stock Price Today
Live Share Price BSE
₹88.00
▼
-1.00 (-1.12%)
As of September 18, 2026, the live Phaarmasia share price (BSE: PHRMASI) is ₹88.00, down 1.12% from the previous close, with shares trading between ₹88.00 and ₹89.00 in today's trading session, and a 52-week range of ₹33.00–₹129.20.
Browse PHRMASI income statement to support your investment research.
Use the Phaarmasia stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Phaarmasia Market Cap
₹58.87 Cr.
PHRMASI P/E Ratio (TTM)
3.41
Phaarmasia P/B Ratio
2.72
EPS (TTM)
₹25.74
Dividend Yield
-
Debt to Equity
0.04
PHRMASI 52 Week High
₹129.20
Phaarmasia 52 Week Low
₹33.00
Operating Margin
2.00%
Profit Margin
26.09%
PHRMASI Revenue (TTM)
₹69.00
EBITDA
₹22.00
Net Income
₹18.00
Total Assets
₹30.00
Total Equity
₹22.00
Phaarmasia Current Share Price Chart
Track the current Phaarmasia share price and stock price with an interactive chart. Analyse PHRMASI price trends, trading volume, historical performance, and volatility across different timeframes — the complete Phaarmasia stock quote in one place.
Phaarmasia Company Profile - Fundamental Screener
Screen Phaarmasia company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PHRMASI shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE486I01016
Phaarmasia Balance Sheet Screener
Screen PHRMASI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 30 | 22 | 31 | 28 | 21 | 22 | 34 | 33 | 22 | 20 |
| Current Assets | 27 | 8 | 18 | 15 | 8 | 9 | 20 | 19 | 8 | 6 |
| Fixed Assets | 1 | 12 | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 22 | 9 | 10 | 11 | 12 | 14 | 13 | 13 | 12 | 12 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 15 | 2 | 4 | 4 | 5 | 7 | 7 | 6 | 5 | 5 |
Phaarmasia Income Statement Screener - Profit & Revenue Analysis
Screen Phaarmasia income statement and profit fundamentals.
Analyze PHRMASI quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Phaarmasia share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 69 | 48 | 25 | 31 | 28 | 18 | 21 | 25 | 25 | 21 | 15 | 22 | 19 |
| Expenses | 47 | 45 | 26 | 31 | 29 | 19 | 20 | 24 | 24 | 20 | 14 | 21 | 18 |
| EBITDA | 22 | 3 | -1 | 0 | -1 | -1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 2.00% | 4.00% | -8.00% | -3.00% | -6.00% | -10.00% | 0.00% | 3.00% | 3.00% | 3.00% | 1.00% | 1.00% | 5.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 21 | 21 | -2 | -1 | -1 | -2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Tax | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 18 | 18 | -2 | -1 | -1 | -2 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| EPS | 25.80 | 25.74 | -2.33 | -0.76 | -1.84 | -2.27 | 0.46 | 0.79 | 1.14 | 0.84 | 0.24 | 0.06 | 0.20 |
Phaarmasia Cash Flow Screener - Liquidity Fundamentals
Screen PHRMASI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 22 | -3 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
| Investing Activities | -12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Financing Activities | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 11 | -3 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Phaarmasia Shareholding Pattern Screener
See Phaarmasia shareholding pattern with promoter, FII, and DII holdings.
Check Phaarmasia promoter holding and ownership changes for PHRMASI on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 73.51% | 73.51% | 73.51% | 73.51% | 73.51% | 73.51% | 73.51% | 73.51% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.05% | 0.06% | 0.06% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 25.66% | 25.67% | 26.18% | 25.82% | 25.82% | 25.81% | 26.17% | 26.18% |
| Other Holding | 0.76% | 0.76% | 0.25% | 0.60% | 0.61% | 0.62% | 0.26% | 0.25% |
| Shareholder Count | 20,301 | 20,286 | 20,620 | 20,512 | 20,497 | 20,404 | 20,682 | 20,642 |
Phaarmasia Share Dividend Screener - Share Yield Analysis
Check Phaarmasia dividend history with payout and yield data.
View Phaarmasia dividend details including ex-dates and amounts for PHRMASI stock.
Phaarmasia Stock Index Membership
See which indices include Phaarmasia stock.
Check PHRMASI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Phaarmasia Market Events Screener - Corporate Actions
Get Phaarmasia corporate actions including splits, bonuses, and buybacks.
Check Phaarmasia stock events that may affect PHRMASI share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-25 | 2026-09-25 | Annual General Meeting | NA | -4.54% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 7.07% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -4.68% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | -0.30% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -2.94% |
| 2025-09-25 | 2025-09-25 | Annual General Meeting | NA | 23.19% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -2.44% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -4.52% |
| 2024-11-05 | 2024-11-05 | Quarterly Result Announcement | NA | 4.89% |
| 2024-09-24 | 2024-09-24 | Annual General Meeting | NA | 17.28% |
Phaarmasia Competitors Screener - Peer Comparison
Screen PHRMASI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Phaarmasia Company Announcements - News Screener
Screen PHRMASI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-10 | Announcement Under Regulation 30_Clarification On Price Movement | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-09 | Reg. 34 (1) Annual Report. | - |
| 2026-09-09 | Intimation Of 45Th Annual General Meeting Of Phaarmasia Limited And Remote E-Voting. | - |
| 2026-08-31 | Clarification sought from Phaarmasia Ltd | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Integrated Financials For The Quarter Ended 30Th June 2026 | - |
| 2026-08-13 | Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 13Th August 2026 At 05.00 PM (IST) | - |
| 2026-08-10 | Board Meeting Intimation for Meeting To Be Held On Thursday 13Th August 2026 At 05.00 PM(IST) | - |
| 2026-07-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-27 | Closure of Trading Window | - |
| 2026-06-13 | Clarification Sought From Phaarmasia Ltd On Price Movement | - |
| 2026-06-10 | Clarification sought from Phaarmasia Ltd | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-29 | Integrated Filing Of Financials For The Quarter And FY Ended 31St March 2026 | - |
| 2026-05-29 | Financial Results For The Quarter And FY Ended 31St March 2026 | - |
| 2026-05-29 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday 29Th May 2026 | - |
| 2026-05-22 | Board Meeting Intimation for Meeting To Be Held On Friday 29Th May 2026 Through Video Conferencing Or Other Audio-Visual Means. | - |
| 2026-04-17 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |